DUTRYS

This brand name is authorized in Albania, Estonia, Croatia, Poland, Romania

Active ingredients

The drug DUTRYS contains one active pharmaceutical ingredient (API):

1 Dutasteride UNII O0J6XJN02I - DUTASTERIDE

Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT. Read about Dutasteride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04CB02	Dutasteride	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CB Testosterone-5-alpha reductase inhibitors
Discover more medicines within G04CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 574/73
Country: EE	Ravimiamet	Identifier(s): 1707230, 1707241, 1707252, 1707263, 1707274
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-020313732
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100364377
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63819001, W63819002, W63819003, W63819004, W63819005